关节内单次注射 0.5%布比卡因对关节软骨的体内影响。

In vivo effects of single intra-articular injection of 0.5% bupivacaine on articular cartilage.

机构信息

Department of Orthopaedic Surgery, University of Pittsburgh, 200 Lothrop Street, BST E1640, Pittsburgh, PA 15261, USA.

出版信息

J Bone Joint Surg Am. 2010 Mar;92(3):599-608. doi: 10.2106/JBJS.I.00425.

Abstract

BACKGROUND

Single intra-articular injections of local anesthetics are commonly used clinically. Recent in vitro studies have demonstrated chondrotoxic effects of local anesthetics, with the greatest emphasis on bupivacaine toxicity. This in vivo study was conducted to determine whether a single intra-articular injection of 0.5% bupivacaine results in chondrocyte morbidity and rapid chondrolysis.

METHODS

Forty-eight Sprague-Dawley rats received a 100-microL injection of sterile 0.9% saline solution (negative control) into one stifle joint and 100 microL of either preservative-free 0.5% bupivacaine (experimental group) or 0.6 mg/mL monoiodoacetate (positive control) into the contralateral joint. The rats were killed at one week, four weeks, twelve weeks, or six months. Live and dead cells were quantified with use of three-dimensional confocal reconstructions of fluorescent-stained tissues at standardized locations on the distal part of the femur. Histological findings were graded with use of a modified Mankin score, and cell density was quantified with use of custom image-analysis software.

RESULTS

In the specimens injected with bupivacaine, the chondral surfaces remained intact as seen with gross and histological examination. No differences in superficial chondrocyte viability or modified Mankin scores were observed between the saline-solution and bupivacaine groups at any location or time point (p > 0.05). Quantitative histological analysis of the bupivacaine-treated knees at six months revealed an up to 50% reduction in chondrocyte density compared with that of the saline-solution-treated knees (p < or = 0.01). Monoiodoacetate injection resulted in death of up to 87% of the superficial chondrocyte cells at one week and chondrolysis at six months. Despite severe histological abnormalities by four weeks after monoiodoacetate injection, cartilage injury was not evident on gross inspection until six months.

CONCLUSIONS

This in vivo study showing reduced chondrocyte density without cartilage tissue loss six months after a single intra-articular injection of 0.5% bupivacaine suggests bupivacaine toxicity. The effects of bupivacaine were milder than those of an injection of 0.6% monoiodoacetate, which resulted in chondrolysis over the same time period.

摘要

背景

局部麻醉药单次关节内注射在临床上很常用。最近的体外研究表明局部麻醉药具有软骨毒性,其中布比卡因的毒性作用受到了最大关注。本体内研究旨在确定单次关节内注射 0.5%布比卡因是否会导致软骨细胞病变和快速软骨溶解。

方法

48 只 Sprague-Dawley 大鼠的一侧膝关节接受 100μL 无菌 0.9%生理盐水(阴性对照)注射,对侧膝关节接受 100μL 无防腐剂的 0.5%布比卡因(实验组)或 0.6mg/mL 单碘乙酸(阳性对照)注射。大鼠在 1 周、4 周、12 周或 6 个月时处死。使用荧光染色组织的三维共聚焦重建,在股骨远端的标准化位置定量活细胞和死细胞。使用改良的 Mankin 评分评估组织学发现,并使用定制的图像分析软件定量细胞密度。

结果

在注射布比卡因的标本中,软骨表面在大体和组织学检查中均保持完整。在任何位置或时间点,生理盐水组和布比卡因组之间的浅层软骨细胞活力或改良 Mankin 评分均无差异(p>0.05)。6 个月时对布比卡因治疗膝关节的定量组织学分析显示,与生理盐水治疗膝关节相比,软骨细胞密度降低了多达 50%(p<或=0.01)。单碘乙酸注射后 1 周可导致 87%的浅层软骨细胞死亡,并在 6 个月时导致软骨溶解。尽管单碘乙酸注射后 4 周时组织学异常严重,但直到 6 个月时才在大体检查中发现软骨损伤。

结论

本体内研究显示,单次关节内注射 0.5%布比卡因 6 个月后软骨细胞密度降低而软骨组织无丢失,提示布比卡因毒性。布比卡因的作用比在相同时间内注射 0.6%单碘乙酸的作用更温和,后者导致软骨溶解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索